Intuitive Surgical, Inc. $ISRG Shares Sold by Moody National Bank Trust Division

Moody National Bank Trust Division lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,089 shares of the medical equipment provider’s stock after selling 1,918 shares during the quarter. Moody National Bank Trust Division’s holdings in Intuitive Surgical were worth $2,316,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC raised its stake in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Intuitive Surgical during the 2nd quarter worth $394,000. Finally, CreativeOne Wealth LLC grew its holdings in shares of Intuitive Surgical by 10.1% during the second quarter. CreativeOne Wealth LLC now owns 6,027 shares of the medical equipment provider’s stock worth $3,275,000 after buying an additional 555 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $471.91 on Wednesday. The stock has a market capitalization of $167.59 billion, a price-to-earnings ratio of 59.81, a price-to-earnings-growth ratio of 3.69 and a beta of 1.66. The business has a 50-day moving average of $499.14 and a 200 day moving average of $513.66. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The business’s quarterly revenue was up 18.8% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,943 shares of company stock valued at $17,279,568 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive is buying the da Vinci and Ion distribution business in Southern Europe to take direct control of sales and service, aiming to improve system availability, customer support and hospital access—moves that can boost recurring service revenue and reduce third‑party distribution costs in a strategic region. Read More.
• Positive Sentiment: Analysts and outlets continue to highlight ISRG’s market leadership versus peers (e.g., Stryker), emphasizing stronger growth and recurring‑revenue characteristics—supportive for long‑term premium valuation if execution and procedure growth persist. Read More.
• Neutral Sentiment: Q4 margins contracted amid tariff pressure but remained high (reported ~37%), with the company pointing to cost efficiencies and recurring revenue strength that partially offset headwinds—this is a mixed signal: profitability is intact but external cost pressures could persist. Read More.
• Neutral Sentiment: Coverage pieces and “trending stock” writeups (Zacks/Yahoo) have increased attention on ISRG—greater retail/institutional focus can amplify moves but doesn’t by itself change fundamentals. Read More.
• Negative Sentiment: Shares have moved lower in recent sessions (closed around $471.91 in the latest session reported), reflecting investor caution about execution, tariff/margin risks and elevated valuation (P/E ~60). Short‑term price action is negative. Read More.
• Negative Sentiment: Data feeds flagged a reported rise in short interest for March, though the published values appear inconsistent—if short interest is rising it could add selling pressure; treat current short‑interest reporting with caution. Read More.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ISRG. Royal Bank Of Canada raised their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Evercore dropped their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research note on Friday, January 23rd. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Wells Fargo & Company raised their target price on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Finally, HSBC upped their price target on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.95.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.